The Ultrasound community is challenged with maintaining current knowledge of trends and advances that could impact decision-making. The goal of this roundtable will be to discuss clinical care topics, such as formulary, storage, use, and dilution practices utilizing three healthcare professionals. Additionally, this panel will discuss the feasibility and value of UEAs, and convey key information related to how to efficiently and safely use these UEAs in current clinical care.
- To understand strategies to reduce the risk of adverse reactions to ultrasound enhancing agents.
- Perform proper administration of various ultrasound enhancing agents.
- How to properly assemble/ prepare the various ultrasound enhancing agents.
- To understand best practices for safe and appropriate use of ultrasound enhancing agents in echocardiography laboratories.
- To recognize the value and appropriate techniques for dilution of ultrasound enhancing agents to improve image quality and mitigate side effects.
The content of this CME webinar is intended for healthcare professionals including Physicians, Imaging Nurses, Administrators, Researchers, and Others.
This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the
Accreditation Council for Continuing Medical Education (ACCME). Northwest Imaging Forums (NWIF) is accredited by the ACCME to provide continuing medical education for physicians. NWIF designates this webinar for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Physician CME Effective: 10/27/2023 – 10/27/2024
Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.
Yvette Carvallo, RDCS, RVS, CCT, FASE
Overlook Medical Center
Atlantic Health System
Summit, New Jersey
Linda D. Gillam, MD, MPH, MACC, FAHA
Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular Service Line
Morristown Medical Center/Atlantic Health System
Professor of Medicine Sidney Kimmel Medical
College at Thomas Jefferson University
Jordan B. Strom, MD, MSc, FACC, FASE
Director, Echocardiography Laboratory,
Division of Cardiovascular Medicine,
Beth Israel Deaconess Medical Center
Assistant Professor of Medicine,
Harvard Medical School, Boston, MA
Ed Kent, B.S. Pharm., R.Ph.
Integrated Health Systems, Pharmacy
Services and Diagnostic Imaging
formulary optimization
Post Falls, Idaho